Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Canntab Therapeutics Ltd (EM) CTABF

Healthcare Drug Manufacturers - Major Cannabis
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:CTABF)

CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)

Newsfile June 14, 2024

Canadian Investment Regulatory Organization Trading Halt - PILL

Canada NewsWire October 5, 2023

Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Newsfile September 18, 2023

IIROC Trade Resumption - PILL

Canada NewsWire November 22, 2022

Canntab Announces Corporate Update

ACCESS Newswire November 22, 2022

IIROC Trading Halt - PILL

Canada NewsWire November 21, 2022

CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

Canada NewsWire August 22, 2022

CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

PR Newswire August 2, 2022

Canntab Corporate Update

PR Newswire June 30, 2022
View More News ››

Opinion & Analysis (EXPM:CTABF)

VIDEO: Extended Release Cannabis Tablets

BTV-Business Television October 2, 2018
View More Opinion ››

Bullboard Posts (EXPM:CTABF)

Agreement with Pathway Health

TORONTO, Dec. 2, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the...
Betteryear2 - December 2, 2021

RE:RE:Huge News

I hear you, I was expecting much more as well. Took the opportunity to buy more.  Not sure why anyone would sell on this news for a...
Druchii - November 11, 2021

RE:Huge News

I agree that it is huge news.  I have to admit though, I am a little disappointed that the share price only went up  10 cents.&...
Eppy - November 11, 2021

Huge News

This news is huge - amazing job Canntab! Company has low market cap and is the only producer with Cannabis 3.0. Seems like a multi...
Druchii - November 11, 2021

RE:Halt?

News is out. Last approval given. The company can now concentrate on production and sales.
Eppy - November 11, 2021

Halt?

ANYONE?
Bullrun - November 10, 2021
View more Bullboard ››

LaFleur Minerals Inc.

LaFleur Minerals Inc.

LaFleur Minerals Inc. explores for lithium and gold deposits in Canada. The company holds interest in the Swanson Gold ...
View More »

Podcasts